BUNDLE TEST OFFERINGS

India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand

The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of analysts' estimate of 976.9 million rupees, according to data compiled by LSEG.